Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

COVID-19 complicates prescribing for children with inflammatory skin disease

Key clinical point: Pediatric dermatologists are more confident keeping children on most systemic treatments during the COVID-19 pandemic.

Major finding: 97% said the COVID-19 pandemic affected their decision about whether to initiate an immunosuppressive medication.

Study details: A task force survey issued to academic pediatric dermatologists in April 2020, to which 37 (100%) responded.

Disclosures: Several coauthors disclosed financial ties to industry.

Citation:

Reynolds et al. Pediatr Dermatol. 2020. doi: 10.1111/pde.14202.